Özgür Kılıç
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Özgür Kılıç has a total of 82 co-authors. Here are the top co-authors by number of shared publications:
- Mehmet Polat
Nevşehir devlet hastanesi
2 shared publications Melda Dilek
Ondokuz Mayis University Faculty of Medicine
2 shared publications- Melda Dilek
Ondokuz Mayis University, School of Medicine
2 shared publications - Yücel Gültekin
Usak University, School of Medicine
2 shared publications - Zerrin Özçelik
Intensive Care Unit, Sancaktepe Şehit Prof. Dr. İlhan Varank Education and Training Hospital, İstanbul, Turkiye
2 shared publications - Adnan Ata
Department of Intensive Care Unit, Kocaeli City Hospital, Kocaeli, Turkiye
1 shared publication
Latest Publications
- Open Access
- 12 February 2026
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 56 (1) , 60-70
Preference of mechanical ventilation modes among intensivists in Türkiye: a national wide, point prevalence study
Background/aim: Invasive mechanical ventilation (IMV) is a fundamental intervention for patients with respiratory failure in intensive care units (ICUs). This nationwide, multicenter point-prevalence study aimed to describe current mechanical ventilation mode preferences (conventional, adaptive, and biphasic) in Turkish ICUs and to report associated clinical outcomes descriptively, without assessing causal relationships. Materials and methods: A nationwide, multicenter point-prevalence study was conducted on 17 April 2024 and included adult patients (≥18 years) who had been receiving IMV for more than 24 h. Data on patient demographics, ventilation mode distribution, ventilatory parameters, and descriptive clinical outcomes on day 28 (weaning status, tracheostomy, and mortality) were recorded without comparative outcome analysis. Results: A total of 426 patients were included. Conventional modes were used in 84.5% of patients, adaptive modes in 10.6%, and biphasic modes in 4.9%. Synchronized intermittent mandatory ventilation (SIMV) was the most commonly used conventional mode. The primary indication for IMV was acute respiratory failure (61%), with pneumonia being the leading cause. Among the 350 orotracheally intubated patients, 25.6% were in the weaning phase on the study day. A total of 59 (16.9%) patients were extubated, 150 (42.9%) underwent tracheostomy, and 64 (18.2%) remained intubated on day 28. Overall, 185 (43.4%) patients died during their ICU stay, 152 (35.7%) remained in the ICU, and 89 (20.9%) were successfully discharged from the ICU. Conclusion: Conventional ventilation modes, particularly SIMV, were more commonly used in Turkish intensive care units (ICUs), whereas adaptive modes were less frequently applied. These patterns may reflect factors such as clinician familiarity, institutional practices, and equipment availability rather than definitive preferences. Although the impact of ventilation modes on clinical outcomes was not comparatively evaluated in this study, the choice of ventilation mode may still influence patient outcomes. Therefore, further prospective and comparative studies are warranted to better elucidate this relationship.
- 12 February 2026
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 56 (1) , 60-70
Open AccessPreference of mechanical ventilation modes among intensivists in Türkiye: a national wide, point prevalence study
Background/aim: Invasive mechanical ventilation (IMV) is a fundamental intervention for patients with respiratory failure in intensive care units (ICUs). This nationwide, multicenter point-prevalence study aimed to describe current mechanical ventilation mode preferences (conventional, adaptive, and biphasic) in Turkish ICUs and to report associated clinical outcomes descriptively, without assessing causal relationships. Materials and methods: A nationwide, multicenter point-prevalence study was conducted on 17 April 2024 and included adult patients (≥18 years) who had been receiving IMV for more than 24 h. Data on patient demographics, ventilation mode distribution, ventilatory parameters, and descriptive clinical outcomes on day 28 (weaning status, tracheostomy, and mortality) were recorded without comparative outcome analysis. Results: A total of 426 patients were included. Conventional modes were used in 84.5% of patients, adaptive modes in 10.6%, and biphasic modes in 4.9%. Synchronized intermittent mandatory ventilation (SIMV) was the most commonly used conventional mode. The primary indication for IMV was acute respiratory failure (61%), with pneumonia being the leading cause. Among the 350 orotracheally intubated patients, 25.6% were in the weaning phase on the study day. A total of 59 (16.9%) patients were extubated, 150 (42.9%) underwent tracheostomy, and 64 (18.2%) remained intubated on day 28. Overall, 185 (43.4%) patients died during their ICU stay, 152 (35.7%) remained in the ICU, and 89 (20.9%) were successfully discharged from the ICU. Conclusion: Conventional ventilation modes, particularly SIMV, were more commonly used in Turkish intensive care units (ICUs), whereas adaptive modes were less frequently applied. These patterns may reflect factors such as clinician familiarity, institutional practices, and equipment availability rather than definitive preferences. Although the impact of ventilation modes on clinical outcomes was not comparatively evaluated in this study, the choice of ventilation mode may still influence patient outcomes. Therefore, further prospective and comparative studies are warranted to better elucidate this relationship.
- Open Access
- 7 December 2024
- Published by Wiley
A Case of Hypoxic-Ischemic Brain Injury Initially Suggesting a Persistent Vegetative State but Resulting in Near-Complete Recovery
A Case of Hypoxic-Ischemic Brain Injury Initially Suggesting a Persistent Vegetative State but Resulting in Near-Complete Recovery
- 7 December 2024
- Published by Wiley
Open AccessA Case of Hypoxic-Ischemic Brain Injury Initially Suggesting a Persistent Vegetative State but Resulting in Near-Complete Recovery
A Case of Hypoxic-Ischemic Brain Injury Initially Suggesting a Persistent Vegetative State but Resulting in Near-Complete Recovery
- 24 May 2024
- Published by Dokuz Eylul Universitesi Tip Fakultesi Dergisi in Dokuz Eylül Üniversitesi Tıp Fakültesi Dergisi
- Vol. 38 (1) , 1-10
The Outcomes of COVID-19 Patients with ARDS Who Received High Flow Nasal Oxygen in Medical Wards Outside Intensive Care Units Under Supervision of Non-intensivists.
Objective: Efficacy of high flow nasal oxygen (HFNO) use in COVID-19 patients who developed ARDS in medical wards is poorly studied. We aimed to investigate whether use of HFNO in wards outside intensive care unit under supervision of non-intensivists has clinical effects on acute respiratory failure and whether it reduces ICU workload. Methods: COVID 19 patients who received HFNO therapy for ARDS in medical wards of an academic hospital were analyzed retrospectively. Primary outcome was the proportion of patients who were successfully weaned from HFNO. Results: 43 patients ( 32 male, median age 61 [54-70] years) were investigated. 14 (33 %) patients weaned from HFNO and 29 (67%) patients failed HFNO and were tranferred to ICU. HFNO was applied in the group of HFNO with success with a median duration of 7 days (4-9) and in the failed group with median 3 days (2-5), p=0.002. Median SpO2 after HFNO was higher in patients with HFNO success compared to with HFNO failure [95 (94-97) vs 93 (92-95), p=0.015]. In the group of HFNO with success, there were more hypocapnic patients than in the group of HFNO with failure [19/29 (66 %) vs 3/14 (21%); p=0.015]. Logistic regression analysis indicated that patients with hypocapnia had 9.8 times the odds of having HFNO failure compared with patients with normocapnia.No patient died among the patients succeded HFNO however 90% of patients who transferred to ICU died. Conclusion: Use of HFNO for COVID-19 patients with ARDS at a non-critical setting seemed to be beneficial in avoiding intubation and reducing workload of ICU. However due to high mortality rate among the HFNO failed group, it would be better to be used undersupervision of intensivists and by skilled team.
- 24 May 2024
- Published by Dokuz Eylul Universitesi Tip Fakultesi Dergisi in Dokuz Eylül Üniversitesi Tıp Fakültesi Dergisi
- Vol. 38 (1) , 1-10
The Outcomes of COVID-19 Patients with ARDS Who Received High Flow Nasal Oxygen in Medical Wards Outside Intensive Care Units Under Supervision of Non-intensivists.
Objective: Efficacy of high flow nasal oxygen (HFNO) use in COVID-19 patients who developed ARDS in medical wards is poorly studied. We aimed to investigate whether use of HFNO in wards outside intensive care unit under supervision of non-intensivists has clinical effects on acute respiratory failure and whether it reduces ICU workload. Methods: COVID 19 patients who received HFNO therapy for ARDS in medical wards of an academic hospital were analyzed retrospectively. Primary outcome was the proportion of patients who were successfully weaned from HFNO. Results: 43 patients ( 32 male, median age 61 [54-70] years) were investigated. 14 (33 %) patients weaned from HFNO and 29 (67%) patients failed HFNO and were tranferred to ICU. HFNO was applied in the group of HFNO with success with a median duration of 7 days (4-9) and in the failed group with median 3 days (2-5), p=0.002. Median SpO2 after HFNO was higher in patients with HFNO success compared to with HFNO failure [95 (94-97) vs 93 (92-95), p=0.015]. In the group of HFNO with success, there were more hypocapnic patients than in the group of HFNO with failure [19/29 (66 %) vs 3/14 (21%); p=0.015]. Logistic regression analysis indicated that patients with hypocapnia had 9.8 times the odds of having HFNO failure compared with patients with normocapnia.No patient died among the patients succeded HFNO however 90% of patients who transferred to ICU died. Conclusion: Use of HFNO for COVID-19 patients with ARDS at a non-critical setting seemed to be beneficial in avoiding intubation and reducing workload of ICU. However due to high mortality rate among the HFNO failed group, it would be better to be used undersupervision of intensivists and by skilled team.
- Open Access
- 30 January 2024
- Published by Wiley
Comparison of the pregnant and non-pregnant women of reproductive age hospitalised due to COVID 19 infection.
Background: COVID 19 affects pregnant women more severe than the nonpregnant women of reproductive age. However, the rate of critical illness and fatality reported from the other studies varied in a wide range in both group. The study aims to investigate the clinical outcomes of pregnant and nonpregnant patients hospitalised with COVID 19 infection. Method: Clinical, radiologoic and laboratory data of pregnant and nonpregnant patients of reproductive age (18-45 years) infected with COVID 19 were analysed retrospectively. Results: Of 153 patients, 123 were nonpregnant and 30 were pregnant. 15 of the 30 pregnant patients delivered during the hopital stay and 6 of them received an urgent cesarean section. Of the six urgent delivery, five were due to respiratory insufficiency related to COVID 19 and one was unrelated to COVID 19. Four preterm birth, one perinatal death but no stillbirth or miscarriage was recorded. The most common symptom and comorbidity were cough and asthma in both group respectively. Semiquantative CT severity score was significantly higher in pregnants than in nonpregnants (9 points vs 2 points, p=0.022). Prognostic laboratory markers including lymphocytopenia, C-reactive protein and D-dimer were markedly worse in the pregnant group. Severe or critical patients were proportionally higher in the pregnants than in the nonpregnants (26% vs 15%, p=0.004). Hospital length of stay (HLOS) was median 4 vs 5 day; p=0.68, mortality rate was 1/123(0.8%) vs 0/30(0%), p=0.62; intensive care unit (ICU) admission rate was 3/123 (2.4%) vs 7/30 (23.3), p<0.001; need for invasive mechanical ventilation (IMV) was 2/123 (1.6%) vs 5/30 (17%), p=0.003 in nonpregnant and pregnant patients respectively. Conclusion: COVID 19 has a more severe course in pregnant women versus nonpregnant control group, but no difference was noted in terms of hospital length of stay and mortality.
- 30 January 2024
- Published by Wiley
Open AccessComparison of the pregnant and non-pregnant women of reproductive age hospitalised due to COVID 19 infection.
Background: COVID 19 affects pregnant women more severe than the nonpregnant women of reproductive age. However, the rate of critical illness and fatality reported from the other studies varied in a wide range in both group. The study aims to investigate the clinical outcomes of pregnant and nonpregnant patients hospitalised with COVID 19 infection. Method: Clinical, radiologoic and laboratory data of pregnant and nonpregnant patients of reproductive age (18-45 years) infected with COVID 19 were analysed retrospectively. Results: Of 153 patients, 123 were nonpregnant and 30 were pregnant. 15 of the 30 pregnant patients delivered during the hopital stay and 6 of them received an urgent cesarean section. Of the six urgent delivery, five were due to respiratory insufficiency related to COVID 19 and one was unrelated to COVID 19. Four preterm birth, one perinatal death but no stillbirth or miscarriage was recorded. The most common symptom and comorbidity were cough and asthma in both group respectively. Semiquantative CT severity score was significantly higher in pregnants than in nonpregnants (9 points vs 2 points, p=0.022). Prognostic laboratory markers including lymphocytopenia, C-reactive protein and D-dimer were markedly worse in the pregnant group. Severe or critical patients were proportionally higher in the pregnants than in the nonpregnants (26% vs 15%, p=0.004). Hospital length of stay (HLOS) was median 4 vs 5 day; p=0.68, mortality rate was 1/123(0.8%) vs 0/30(0%), p=0.62; intensive care unit (ICU) admission rate was 3/123 (2.4%) vs 7/30 (23.3), p<0.001; need for invasive mechanical ventilation (IMV) was 2/123 (1.6%) vs 5/30 (17%), p=0.003 in nonpregnant and pregnant patients respectively. Conclusion: COVID 19 has a more severe course in pregnant women versus nonpregnant control group, but no difference was noted in terms of hospital length of stay and mortality.
- 28 February 2023
- Published by Ordu University in MIDDLE BLACK SEA JOURNAL OF HEALTH SCIENCE
- Vol. 9 (1) , 135-146
Hypernatremia in Critically Ill COVID-19 Patients: Is it a manifestation of COVID-19 or acquired in the ICU?
Objective: It has been noted that COVID-19 patients experienced electrolyte problems more frequently, and these disturbances were linked to unfavorable results. The purpose of this study was to investigate the incidence and consequences of hypernatremia in severely ill COVID-19 patients receiving intensive care (ICU). Methods: Retrospective data analysis was done on COVID-19 patients who were admitted to ICUs over a six-month period at two centers. Results: Data from 270 patients were collected in total. 138 (51%) patients developed hypernatremia (Na >145 mmol/l) during ICU stay. Hypernatremia was observed to be more in older or ventilated patients, whereas less in patients with chronic kidney disease. However, in patients with and without hypernatremia, unfavorable outcomes like length of stay (LOS) or mortality were comparable. Frequency of hypertension, septic shock as well as SOFA score, and serum BUN levels were significantly higher in moderate to severe hypernatremic (Na ≥150 mmol/l) vs mild hypernatremic (Na=146-149 mmol/l) group. Moderate to severe hypernatremia had worse prognosis than the mild group: ICU LOS (12 vs 9-day, p=0.033), ICU mortality (86% vs 61%, p=0.001 and 28-day mortality (89% vs 68%, p=0.004). Elevated serum BUN levels and moderate to severe hypernatremia were independent predictors of both ICU and 28-day mortality. Conclusion: Critically ill COVID-19 patients experienced hypernatremia more frequently than expected, suggesting that hypernatremia may be a manifestation of systemic involvement of COVID-19 rather than iatrogenic. Patients with and without hypernatremia were found to have similar outcomes.
- 28 February 2023
- Published by Ordu University in MIDDLE BLACK SEA JOURNAL OF HEALTH SCIENCE
- Vol. 9 (1) , 135-146
Hypernatremia in Critically Ill COVID-19 Patients: Is it a manifestation of COVID-19 or acquired in the ICU?
Objective: It has been noted that COVID-19 patients experienced electrolyte problems more frequently, and these disturbances were linked to unfavorable results. The purpose of this study was to investigate the incidence and consequences of hypernatremia in severely ill COVID-19 patients receiving intensive care (ICU). Methods: Retrospective data analysis was done on COVID-19 patients who were admitted to ICUs over a six-month period at two centers. Results: Data from 270 patients were collected in total. 138 (51%) patients developed hypernatremia (Na >145 mmol/l) during ICU stay. Hypernatremia was observed to be more in older or ventilated patients, whereas less in patients with chronic kidney disease. However, in patients with and without hypernatremia, unfavorable outcomes like length of stay (LOS) or mortality were comparable. Frequency of hypertension, septic shock as well as SOFA score, and serum BUN levels were significantly higher in moderate to severe hypernatremic (Na ≥150 mmol/l) vs mild hypernatremic (Na=146-149 mmol/l) group. Moderate to severe hypernatremia had worse prognosis than the mild group: ICU LOS (12 vs 9-day, p=0.033), ICU mortality (86% vs 61%, p=0.001 and 28-day mortality (89% vs 68%, p=0.004). Elevated serum BUN levels and moderate to severe hypernatremia were independent predictors of both ICU and 28-day mortality. Conclusion: Critically ill COVID-19 patients experienced hypernatremia more frequently than expected, suggesting that hypernatremia may be a manifestation of systemic involvement of COVID-19 rather than iatrogenic. Patients with and without hypernatremia were found to have similar outcomes.
- Open Access
- 1 June 2022
- Published by Galenos Yayinevi in Turkish Journal of Anaesthesiology and Reanimation
- Vol. 50 (3) , 194-200
Can Gastric Volume be Accurately Estimated by Ultrasound?
Cross-sectional area,gastric volume,ultrasonography
- 1 June 2022
- Published by Galenos Yayinevi in Turkish Journal of Anaesthesiology and Reanimation
- Vol. 50 (3) , 194-200
Open AccessCan Gastric Volume be Accurately Estimated by Ultrasound?
Cross-sectional area,gastric volume,ultrasonography
- Open Access
- 6 January 2022
- Published by Turkish Society of Cardiology in Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology
- Vol. 50 (1) , 70-78
Percutaneous closure of an iatrogenic ventricular septal defect associated with transcatheter aortic valve implantation
An 81-year-old man who had dyspnea was admitted to our hospital with a diagnosis of severe aortic stenosis. A transcatheter aortic valve implantation was successfully performed with a 29 mm Edwards Sapien XT valve using a transfemoral access. After the procedure, the echocardiography showed a restrictive ventricular septal defect (VSD) in the membranous septum. As the patient had no symptoms, it was decided to follow him up conservatively. However, he was readmitted within three weeks with symptoms suggestive of biventricular failure. A control echocardiography revealed a membranous VSD, 8 mm in size, right chambers dilatation with moderate tricuspid regurgitation, and systolic pulmonary artery pressure of 60 mm Hg. The previously deployed aortic valve was normal in function. The decision to perform a percutaneous VSD closure was made. The defect was then closed with a 10 mm muscular VSD occluder. During and after the procedure, there was no dysfunction in the bioprosthetic aortic valve. At the one-year follow-up, the patient was still asymptomatic.
- 6 January 2022
- Published by Turkish Society of Cardiology in Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology
- Vol. 50 (1) , 70-78
Open AccessPercutaneous closure of an iatrogenic ventricular septal defect associated with transcatheter aortic valve implantation
An 81-year-old man who had dyspnea was admitted to our hospital with a diagnosis of severe aortic stenosis. A transcatheter aortic valve implantation was successfully performed with a 29 mm Edwards Sapien XT valve using a transfemoral access. After the procedure, the echocardiography showed a restrictive ventricular septal defect (VSD) in the membranous septum. As the patient had no symptoms, it was decided to follow him up conservatively. However, he was readmitted within three weeks with symptoms suggestive of biventricular failure. A control echocardiography revealed a membranous VSD, 8 mm in size, right chambers dilatation with moderate tricuspid regurgitation, and systolic pulmonary artery pressure of 60 mm Hg. The previously deployed aortic valve was normal in function. The decision to perform a percutaneous VSD closure was made. The defect was then closed with a 10 mm muscular VSD occluder. During and after the procedure, there was no dysfunction in the bioprosthetic aortic valve. At the one-year follow-up, the patient was still asymptomatic.
- 24 May 2021
- Published by Galenos Yayinevi in Turkish Journal of Colorectal Disease
- Vol. 32 (2) , 122-128
The Prognostic Factors on Survival Rates for Patients with Stage II-III Colon Cancer
- 24 May 2021
- Published by Galenos Yayinevi in Turkish Journal of Colorectal Disease
- Vol. 32 (2) , 122-128
The Prognostic Factors on Survival Rates for Patients with Stage II-III Colon Cancer